State-owned Sinopharm promotes TCM mixed ownership reform

Sinopharm, a large medicine group controlled by China’s State-owned Asset Supervision and Administration Commission of the State Council, is promoting mixed ownership reform in its Traditional Chinese Medicine (TCM) branch.

“Sinopharm has been a pilot of mixed ownership reform and accumulated lots of experience in the field,” said Zeng Bing, deputy general manager of Sinopharm.

“Traditional Chinese Medicine now is developing rapidly, and great efforts of mixed ownership reform will be continuously put on this area when we boost the whole industrial chain layout.”